Page last updated: 2024-08-26

nsc-172755 and rifampin

nsc-172755 has been researched along with rifampin in 13 studies

Research

Studies (13)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (7.69)18.2507
2000's5 (38.46)29.6817
2010's4 (30.77)24.3611
2020's3 (23.08)2.80

Authors

AuthorsStudies
González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M1
Anagonou, SY; Foundohou, J; Gninafon, M; Josse, R; Kinde-Gazard, D; Tawo, L1
Aguiar, J; Debacker, M; Meyers, WM; Portaels, F; Steunou, C; Zinsou, C1
Affolabi, D; Anagonou, S; Martin, A; Odoun, M; Palomino, JC; Portaels, F1
Affolabi, D; Anagonou, S; Kestens, L; Koukpemedji, L; Martin, A; Odoun, M; Palomino, JC; Portaels, F; Sanoussi, N1
Affolabi, D; Anagonou, SY; Asiedu, K; Barogui, YT; Dossou, AD; Johnson, CR; Portaels, F; Sopoh, GE; Zohoun, T1
Adeye, A; Ardant, MF; Chauty, A; Cottin, J; Goundoté, A; Ji, B; Ladikpo, T; Landier, J; Marsollier, L; Pluschke, G; Ruf, T1
Barogui, YT; Brun, LV; Dossou, AD; Johnson, RC; Pluschke, G; Ruf, MT; Sopoh, GE1
Agbo, IE; Amoussouhoui, AS; Aoulou, P; Boyer, M; Houezo, JG; Johnson, RC; Nichter, M; Sopoh, GE; Wadagni, AC1
Johnson, PDR1
Abass, KM; Agossadou, D; Ampadu, EO; Asiedu, KB; Chauty, A; Egondi, TW; Frimpong, M; Ganlonon, L; Gateau, T; Grosset, J; Lehman, L; Macdonald, JM; Marion, E; Ochieng Otieno, M; Ohene, SA; Omollo, R; Paintsil, A; Phillips, RO; Robert, J; Saizonou, R; Sarfo, FS; Sarpong, G; Sarpong, NF; Saunderson, P; Stienstra, Y; Thompson, W; Tiendrebeogo, A; Treadwell, T; van der Werf, TS; Wansbrough-Jones, M; Wilson, T1
Affolabi, D; Agbla, SC; Agodokpessi, G; de Jong, BC; Fandohan, M; Massou, F; Rigouts, L; Wachinou, AP1
Addo, J; Anagonou, ES; Ayelo, AG; Biswas, N; Calderon, F; Cruz, I; Della Pasqua, O; Díez, G; Gine-March, A; Gnimavo, RS; Herrador, Z; Houezo, JG; Johnson, RC; Kpoton, GG; Mendoza-Losana, A; Mignanwande, FZ; Orford, L; Ramón-García, S; Sáez-López, E; Sopoh, GE; Vlasakakis, G1

Trials

2 trial(s) available for nsc-172755 and rifampin

ArticleYear
Rifampicin and clarithromycin (extended release) versus rifampicin and streptomycin for limited Buruli ulcer lesions: a randomised, open-label, non-inferiority phase 3 trial.
    Lancet (London, England), 2020, 04-18, Volume: 395, Issue:10232

    Topics: Administration, Oral; Adolescent; Adult; Anti-Bacterial Agents; Benin; Buruli Ulcer; Child; Clarithromycin; Delayed-Action Preparations; Drug Therapy, Combination; Female; Ghana; Humans; Male; Rifampin; Streptomycin; Wound Healing; Young Adult

2020
Comparison of 8 weeks standard treatment (rifampicin plus clarithromycin) vs. 4 weeks standard plus amoxicillin/clavulanate treatment [RC8 vs. RCA4] to shorten Buruli ulcer disease therapy (the BLMs4BU trial): study protocol for a randomized controlled mu
    Trials, 2022, Jul-08, Volume: 23, Issue:1

    Topics: Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Benin; Buruli Ulcer; Clarithromycin; Clinical Trials, Phase II as Topic; Humans; Multicenter Studies as Topic; Randomized Controlled Trials as Topic; Rifampin; Treatment Outcome

2022

Other Studies

11 other study(ies) available for nsc-172755 and rifampin

ArticleYear
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
    Journal of medicinal chemistry, 2008, Nov-13, Volume: 51, Issue:21

    Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship

2008
[Initial resistance to streptomycin, isoniazid, rifampicin and ethambutol in bacillus-laden tuberculosis patients at the National Center of Pneumo-physiology at Cotonou (Benin)].
    Bulletin de la Societe de pathologie exotique (1990), 1993, Volume: 86, Issue:2

    Topics: Benin; Drug Resistance, Microbial; Ethambutol; Humans; Isoniazid; Mycobacterium; Rifampin; Streptomycin; Tuberculosis, Pulmonary

1993
Buruli ulcer recurrence, Benin.
    Emerging infectious diseases, 2005, Volume: 11, Issue:4

    Topics: Anti-Bacterial Agents; Benin; Endemic Diseases; Follow-Up Studies; Humans; Mycobacterium Infections, Nontuberculous; Mycobacterium ulcerans; Recurrence; Rifampin; Skin Diseases, Bacterial; Streptomycin

2005
Evaluation of direct detection of Mycobacterium tuberculosis rifampin resistance by a nitrate reductase assay applied to sputum samples in Cotonou, Benin.
    Journal of clinical microbiology, 2007, Volume: 45, Issue:7

    Topics: Antitubercular Agents; Bacterial Proteins; Benin; Colorimetry; DNA-Directed RNA Polymerases; Drug Resistance, Bacterial; Gene Expression Regulation, Bacterial; Humans; Mycobacterium tuberculosis; Nitrate Reductase; Rifampin; Sensitivity and Specificity; Sputum; Tuberculosis, Pulmonary

2007
Rapid detection of multidrug-resistant Mycobacterium tuberculosis in Cotonou (Benin) using two low-cost colorimetric methods: resazurin and nitrate reductase assays.
    Journal of medical microbiology, 2008, Volume: 57, Issue:Pt 8

    Topics: Bacterial Proteins; Benin; Colorimetry; Drug Resistance, Bacterial; Drug Resistance, Multiple; Humans; Mycobacterium tuberculosis; Nitrate Reductase; Rifampin

2008
Management of Mycobacterium ulcerans infection in a pregnant woman in Benin using rifampicin and clarithromycin.
    The Medical journal of Australia, 2008, Nov-03, Volume: 189, Issue:9

    Topics: Adult; Antibiotics, Antitubercular; Benin; Buruli Ulcer; Clarithromycin; Female; Humans; Mycobacterium ulcerans; Pregnancy; Pregnancy Complications, Infectious; Rifampin; Skin Transplantation

2008
Oral treatment for Mycobacterium ulcerans infection: results from a pilot study in Benin.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2011, Jan-01, Volume: 52, Issue:1

    Topics: Administration, Oral; Adolescent; Adult; Aged; Anti-Bacterial Agents; Benin; Buruli Ulcer; Child; Child, Preschool; Clarithromycin; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Mycobacterium ulcerans; Pilot Projects; Rifampin; Treatment Outcome; Young Adult

2011
Histopathological changes and clinical responses of Buruli ulcer plaque lesions during chemotherapy: a role for surgical removal of necrotic tissue?
    PLoS neglected tropical diseases, 2011, Volume: 5, Issue:9

    Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Benin; Biopsy; Buruli Ulcer; Child; Child, Preschool; Debridement; Drug Therapy; Female; Histocytochemistry; Humans; Immunohistochemistry; Male; Microscopy; Middle Aged; Mycobacterium ulcerans; Rifampin; Skin; Streptomycin; Treatment Outcome; Young Adult

2011
Implementation of a decentralized community-based treatment program to improve the management of Buruli ulcer in the Ouinhi district of Benin, West Africa.
    PLoS neglected tropical diseases, 2018, Volume: 12, Issue:3

    Topics: Anti-Bacterial Agents; Benin; Buruli Ulcer; Community Health Services; Disease Management; Early Medical Intervention; Female; Health Impact Assessment; Health Plan Implementation; Humans; Male; Mycobacterium ulcerans; Rifampin; Streptomycin

2018
Surgery for Buruli ulcer in the antibiotic era.
    The Lancet. Infectious diseases, 2018, Volume: 18, Issue:6

    Topics: Anti-Bacterial Agents; Benin; Buruli Ulcer; Humans; Mycobacterium ulcerans; Rifampin

2018
Spot specimen testing with GeneXpert MTB/RIF results compared to morning specimen in a programmatic setting in Cotonou, Benin.
    BMC infectious diseases, 2021, Sep-20, Volume: 21, Issue:1

    Topics: Benin; Drug Resistance, Bacterial; Humans; Mycobacterium tuberculosis; Rifampin; Sensitivity and Specificity; Sputum

2021